
Sign up to save your podcasts
Or


Send us a text
π§ͺ Trials:
RESHAPE-HF2: β HF hospitalizations with transcatheter edge-to-edge repair vs medical therapy.
MATTR: Transcatheter approach non-inferior to surgical repair.
π§© Clinical Takeaway:
Game-changing for patients too high risk for surgery.
Less peri-op risk, faster recovery β mitral repair is heading the way of TAVR.
By Brilliant Board Review & CMESend us a text
π§ͺ Trials:
RESHAPE-HF2: β HF hospitalizations with transcatheter edge-to-edge repair vs medical therapy.
MATTR: Transcatheter approach non-inferior to surgical repair.
π§© Clinical Takeaway:
Game-changing for patients too high risk for surgery.
Less peri-op risk, faster recovery β mitral repair is heading the way of TAVR.